Oscar Health (NYSE:OSCR) Lifted to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of Oscar Health (NYSE:OSCR) from a sell rating to a hold rating in a report published on Wednesday morning, Zacks.com reports.

According to Zacks, “Oscar Health Inc. is a digital health-insurance company. Oscar Health Inc. is based in New York. “

A number of other research analysts have also recently commented on the company. Credit Suisse Group decreased their price target on Oscar Health from $21.00 to $10.00 and set an outperform rating on the stock in a research note on Friday, January 7th. Wells Fargo & Company cut Oscar Health from an overweight rating to an equal weight rating and cut their price target for the company from $25.00 to $9.00 in a research note on Thursday, January 6th. Morgan Stanley cut their price target on Oscar Health from $22.00 to $19.00 and set an overweight rating on the stock in a research note on Friday, December 17th. Finally, The Goldman Sachs Group began coverage on Oscar Health in a report on Tuesday, December 14th. They set a sell rating and a $6.50 price objective on the stock. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of Hold and an average price target of $16.42.

Shares of Oscar Health stock opened at $7.27 on Wednesday. Oscar Health has a fifty-two week low of $6.59 and a fifty-two week high of $37.00. The stock has a 50 day moving average of $9.45 and a 200 day moving average of $14.47.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Wednesday, November 10th. The company reported ($1.02) earnings per share for the quarter, missing the consensus estimate of ($0.68) by ($0.34). The business had revenue of $443.98 million during the quarter. Oscar Health had a negative return on equity of 59.62% and a negative net margin of 37.53%. Equities research analysts predict that Oscar Health will post -3.42 EPS for the current year.

A number of hedge funds have recently added to or reduced their stakes in OSCR. Sandy Spring Bank purchased a new stake in Oscar Health in the 3rd quarter worth approximately $27,000. Advisor Group Holdings Inc. grew its stake in Oscar Health by 155.2% in the 2nd quarter. Advisor Group Holdings Inc. now owns 1,725 shares of the company’s stock worth $37,000 after acquiring an additional 1,049 shares during the period. Pinz Capital Management LP purchased a new stake in Oscar Health in the 2nd quarter worth approximately $69,000. Royal Bank of Canada grew its stake in shares of Oscar Health by 3,837.2% during the 2nd quarter. Royal Bank of Canada now owns 5,709 shares of the company’s stock valued at $123,000 after buying an additional 5,564 shares during the period. Finally, Two Sigma Advisers LP purchased a new stake in shares of Oscar Health during the 3rd quarter valued at $202,000. 87.04% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Company Profile

Oscar Health, Inc provides health insurance products and services to individuals, families, and businesses in the United States. The company was formerly known as Mulberry Health Inc and changed its name to Oscar Health, Inc in January 2021. Oscar Health, Inc was founded in 2012 and is headquartered in New York, New York.

Further Reading: Compound Interest and Why It Matters When Investing

Get a free copy of the Zacks research report on Oscar Health (OSCR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Oscar Health (NYSE:OSCR)

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.